We have explored the value of CSF interleukin (IL)-10 in PCNSL and found that CSF IL-10 ≥ 8.2 pg/ml can differentiate PCNSL well from other CNS tumors, with sensitivity and specialty of 95.5% and 96.1%, respectively [12]. This evidence concerns the gene IL10 and central nervous system neoplasm.